Dark

NEOS
Neos Therapeutics, Inc. Common Stock
stock NASDAQ

Inactive

Mar 19, 2021

1.15USD-2.542%(-0.03)15,005,940

Pre-market

0.00USD-100.000%(-1.18)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsMore

open chart

CEO

Gerald McLaughlin

Headquarters

Grand Prairie, Texas, USA

Industry

Drug Manufacturers

OMER XLV

Profile

Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder using its drug delivery technologies.